Tempest Historical Financial Ratios
| TPST Stock | USD 1.26 0.04 3.08% |
Tempest Therapeutics is promptly reporting on over 85 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 1.65, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 21.71 will help investors to properly organize and evaluate Tempest Therapeutics financial condition quickly.
Tempest |
About Tempest Financial Ratios Analysis
Tempest TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Tempest Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Tempest financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Tempest Therapeutics history.
Tempest Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Tempest Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Tempest Therapeutics sales, a figure that is much harder to manipulate than other Tempest Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Tempest Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Tempest Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tempest Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy Tempest Stock please use our How to Invest in Tempest Therapeutics guide.At this time, Tempest Therapeutics' PTB Ratio is comparatively stable compared to the past year. Stock Based Compensation To Revenue is likely to gain to 21.71 in 2024, whereas Free Cash Flow Yield is likely to drop (0.43) in 2024.
| 2021 | 2023 | 2024 (projected) | Payables Turnover | 1.28 | 0.45 | 0.43 | Days Of Inventory On Hand | 454.38 | 408.94 | 429.39 |
Tempest Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Tempest Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tempest Therapeutics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 1.58 | (0.0146) | 0.55 | 0.73 | 2.53 | 3.14 | |
| Book Value Per Share | 65.52 | (2.2K) | 9.53 | 1.57 | 1.74 | 1.65 | |
| Free Cash Flow Yield | (0.45) | (19.03) | (1.3) | (2.38) | (0.41) | (0.43) | |
| Operating Cash Flow Per Share | (45.11) | (609.32) | (6.85) | (2.69) | (1.77) | (1.86) | |
| Capex To Depreciation | 0.38 | 0.15 | 0.36 | 0.88 | 0.45 | 0.42 | |
| Pb Ratio | 1.58 | (0.0146) | 0.55 | 0.73 | 2.53 | 3.14 | |
| Free Cash Flow Per Share | (45.55) | (610.93) | (6.88) | (2.74) | (1.79) | (1.87) | |
| Roic | (0.75) | 0.29 | (0.52) | (0.89) | (0.76) | (0.8) | |
| Net Income Per Share | (48.77) | (612.56) | (7.8) | (3.18) | (1.91) | (2.01) | |
| Payables Turnover | 0.7 | 0.76 | 1.28 | 1.64 | 0.45 | 0.43 | |
| Cash Per Share | 69.5 | 603.01 | 13.67 | 2.7 | 2.54 | 2.42 | |
| Pocfratio | (2.24) | (0.0527) | (0.77) | (0.43) | (2.48) | (2.6) | |
| Capex To Operating Cash Flow | (0.009631) | (0.002629) | (0.005201) | (0.0181) | (0.006214) | (0.006525) | |
| Pfcf Ratio | (2.22) | (0.0525) | (0.77) | (0.42) | (2.46) | (2.59) | |
| Days Payables Outstanding | 518.7 | 479.65 | 284.81 | 222.94 | 809.51 | 769.04 | |
| Pe Ratio | (2.07) | (0.0524) | (0.68) | (0.36) | (2.3) | (2.42) | |
| Return On Tangible Assets | (0.59) | (0.84) | (0.4) | (0.8) | (0.57) | (0.6) | |
| Earnings Yield | (0.48) | (19.08) | (1.48) | (2.77) | (0.43) | (0.46) | |
| Net Debt To E B I T D A | 1.33 | 0.86 | 1.25 | 0.27 | 0.65 | 0.76 | |
| Current Ratio | 5.68 | 6.15 | 3.44 | 4.53 | 4.29 | 7.98 | |
| Tangible Book Value Per Share | 65.52 | (2.2K) | 9.53 | 1.57 | 1.74 | 1.65 | |
| Graham Number | 265.16 | 5.5K | 40.88 | 10.6 | 8.65 | 8.21 | |
| Shareholders Equity Per Share | 64.07 | (2.2K) | 9.53 | 1.57 | 1.74 | 1.65 | |
| Debt To Equity | 0.0363 | (0.0355) | 0.51 | 1.22 | 0.43 | 0.29 | |
| Capex Per Share | 0.43 | 1.6 | 0.0356 | 0.0487 | 0.011 | 0.0105 | |
| Graham Net Net | 54.03 | (2.3K) | 7.06 | 0.31 | 0.93 | 0.89 | |
| Interest Debt Per Share | 1.19 | 78.15 | 5.23 | 2.05 | 0.84 | 0.8 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.